The fight to cure cancer has been an ongoing battle in our society for decades. In 2014, The National Cancer Institute estimates that 14.5 million US citizens were fighting the disease, a number that is predicted to reach 19 million by 2024. Though, thanks to inviduals like Erik Lefkofsky and companies like Tempus, those battling cancer do not have to do it alone and can count on these individuals and companies who are continually trying to improve their care.
Erik Lefkofsky co-founded Tempus with the objective to transform they way individuals faced with cancer receive treatment. Everyday advances are being made in how cancer is both diagnosed and treated. Tempus has been leading the way in precision medicine, pioneering the way that patient information is taken and analyzed. By creating models that incorporates some of the most important data in a patients care, physician notes, this model comes equipped with natural language processing and character recognition making it so that all data collected on a patient is specific to their individual cases, significantly improving the effectiveness of finding the right treatment course.
Erik Lefkofsky, an entrepreneur and philanthropist, has had an intimate relationship with cancer when him and his wife first founded Tempus as his wife’s sister passed away from it, and it was only later that his wife as well was diagnosed with breast cancer. The effort in revolutionizing the way those battling cancer receive their care is an objective that has had personal meaning to Lefkofsky.
Lefkofsky has found himself successful in many of his endeavors and investments in technological advances that have potential to improve the future for all, but it is in his feats of aiding those who are caring for a loved with cancer or who are fighting the disease themselves, that demonstrates the mark that Lefkofsky is trying to make, a stronger tomorrow.